INTRODUCTION
Maximizing the efficacy of a Boron Neutron Capture Therapy (BNCT) modality requires improvements in two areas: development of better boron-delivering drugs and better tailoring of the epithermal neutron beam. Previous attempts at the latter have not always been successful in predicting optimal in-phantom results, often assuming that all neutrons within a certain "useful" energy range are equally valuable for BNCT purposes. Some studies have recognized that higher energy epithermal neutrons ("' 10 ke V) and more forward-directed Pursuit of a more useful in-air figure-of-merit remains an elusive, yet highly desirable goal.
3 weighted tumor dose at the brain midpoint to the maximum RBE-weighted tissue dose:
where DB, DN, Dn, and D-y refer respectively to the physical doses due to the 10 B(n,a) boron, 14 N(n,p) nitrogen, 1 H(n,n') proton-recoil, and the 'Y dose via the 1 H(n,"f) capture reaction. The physical doses were multiplied by a corresponding compound factor (CF) or relative biological effectiveness (RBE TGbm is a ratio, it is independent of an actual defined limit on Dtis.
(Max.).
With TGbm established as an appropriate in-phantom figure-of-merit for gauging beam quality, an in-air parameter can be sought to predict this quantity as a function of the neutron spectrum.
NEUTRON ENERGY DOSE RESPONSE

Modeling
The first step in predicting the dose response of any neutron energy spectrum was modeling a large number (rv100) of nearly monoenerge~ic neutron energy distributions through a head phantom using the MCNP 5 Monte Carlo code. Each simulation consisted of a monodirectional neutron beam with a narrow, uniform energy distribution, incident onto the full surface of a head phantom. A modified Snyder 6 head phantom was used, consisting of skin, bone, and brain in the geometry with $Urfaces described by the following equations:
Moderator Optimization
This new method of evaluating an in-air neutron beam spectrum was initially tested by comparing the TGbm prediction against that calculated with the INEEL Monte Carlo treatment planning code, BNCT _RTPE.9 There are many differences in these two models, including elemental composition, phantom geometry, beam size, and angular distribution. Therefore, the values of TGbm calculated with each method were expected to be quite different. However, each method should produce the same results in judging different neutron spectra against each other. Figure 2 shows that for two different moderators (Al/ AlF 3 and D 2 0), the same thickness of moderator is predicted as optimal, independent of the model chosen. It should be noted that because the database includes data only from monodirectional neutrons, which are inherently more penetrating, it cannot be used to produce accurate absolute doses and can only be used to gauge different neutron spectra of similar J/<I> against each other. In particular, if there are additional constraints on treatment other than a maximum tissue dose ( eg: surface dose or treatment time), great care must be taken to not misinterpret the results
given by the database. For instance, previous LBNL optimization constraints have placed a limit of 10.0 Gy-eq on the surface dose, in addition to a maximum tissue dose constraint of 12.5 Gy-eq. In beams where BNCT _RTPE calculates a surface dose of 10.0 Gy-eq, the database response is only 8.5 Gy-eq. This seems to be a consistent underrepresentation for beams with a typical J /<I> of "'0.8. This should be considered when a skin dose constraint is applied. To be fully useful in predicting dose responses, however, the database should be expanded to allow for angular dependence.
The Ideal Neutron Spectrum
Using a Monte Carlo code such as BNCT -RTPE or MCNP can take many hours or days of computer time, whereas evaluating an in-air neutron spectrum with the predetermined energy-dependant dose response database is instantaneous. Because the database allows instantaneous evaluation of a neutron energy spectrum, it becomes a powerful tool in determining the effect of changing existing neutron beams, or in quickly evaluating hypothetical neutron spectra.
This ability to instantly evaluate any input spectrum allows investigation into determining an "ideal" neutron spectrum for BNCT, which would produce the maximum value of Therefore, TGbm(2.0cm) and TGbm(3.5cm) have also been plotted in Figure 3 . These values are defined as in Equation 1, with the exception that Dtis(Max.) is assumed to be at 2.0 em and 3.5 em, respectively. These values were chosen as they represent two extremes in maximum dose position. The BMRR tissue dose peaks at 2.0 em, while the maximum depth at which monodirectional beams peak are at 3.5 em. If the LBNL spectrum were monodirectional, it would peak close to 3.5 em. It's actual peak is at 2.9 em, the TGbm curve for which looks similar·to that of a 3.5 em peak. By plotting TGbm this way, the dose maximum in the 3.5 em line. Because these energies individually have TGbm maxima at 3.5 em, their contribution to the dose at 2.0 em is lower. It is nearly impossible, however, to conceive of a neutron spectrum which is composed primarily of neutrons at this energy, yet which has a maximum at 2.0 em and this artifact cannot be exploited to produce a higher TGbm than 3.
The ideal neutron spectrum for BNCT is therefore shown, as in Figure 4 , to be a spread of energies between "'4 keV and "'40 keV, so long as the number of neutrons above rv20 keV is kept low enough to not adversely affect the position of Dtis(Max.). Also shown are the BMRR beam and the LBNL accelerator-produced Fluental/Tefion-moderated beam.
The LBNL beam is quite close to the ideal spectrum, demonstrating that there are few advantages to be gained by further alteration of the energy spectrum. The dose response database predicts that the· BMRR, LBNL, and ideal spectra yield, respectively, a TGbm of 2.0, 2.9 and 3.0. Again, these values assume that each spectrum is made purely monodirectional and only reflect the relative differences in energy spectrum.
CONCLUSIONS
This study has demonstrated the strong importance of the shape of the neutron energy spectrum for usage in BNCT, which we have taken advantage of in shaping a nearly ideal spectrum. Our accelerator-based spectrum produces a monodirectional TGbm that is within 5% of the maximum that can be realized, leading us to conclude that future beam shaping should focus on improving directionality and beam intensity. The dose response database has proven a valuable tool in instantaneous evaluation of an in-air spectrum to predict inphantom parameters. However, to be fully applicable, it must be expanded to account for the angular distribution of a neutr.on beam. It would also benefit from expansion to allow for variable beam sizes and phantom geometries, after which it can be distributed for public use in optimizing neutron beam designs.
